title: Phase II study of L-alanosine (NSC 153353) in patients with advanced breast cancer. A Southwest Oncology Group study.
authors.affiliation: University of Texas Health Science Center, San Antonio.
authors.forename: D D
authors.initials: DD
authors.lastname: Von Hoff
authors.forename: S J
authors.initials: SJ
authors.lastname: Green
authors.forename: J A
authors.initials: JA
authors.lastname: Neidhart
authors.forename: C
authors.initials: C
authors.lastname: Fabian
authors.forename: T
authors.initials: T
authors.lastname: Budd
authors.forename: J F
authors.initials: JF
authors.lastname: Boyd
authors.forename: C K
authors.initials: CK
authors.lastname: Osborne
mesh_terms: D000230:Adenocarcinoma / Q000188:drug therapy*; D000328:Adult; D000368:Aged; D000409:Alanine / Q000009:adverse effects / Q000031:analogs & derivatives / Q000627:therapeutic use; D000903:Antibiotics, Antineoplastic / Q000009:adverse effects / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy*; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008875:Middle Aged
chemical_list: D000903:Antibiotics, Antineoplastic; C000082:alanosine; D000409:Alanine